Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

VYOME HOLDINGS, INC. (HIND) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $1.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2025-08-14

  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $1.00K, a 85.71% decline year-over-year.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was -$6.00K.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-09-30 was $1.00K, a 0.00% change year-over-year.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-06-30 was $7.00K.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$16.00K.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $4.00K, a 86.21% decline from fiscal 2021.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was $29.00K.
  • VYOME HOLDINGS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was -$113.00K.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2025-06-30$1.00K
10-Q · filed 2025-08-14
-$5.00K
10-Q · filed 2025-08-14
2025-03-31-$6.00K
10-Q · filed 2025-05-20
2024-12-31-$16.00K
10-K · filed 2025-04-04
2024-09-30$1.00K
10-Q · filed 2024-11-14
$8.00K
derived: sum of 2 quarters · filed 2025-08-14
$0.00
derived: sum of 3 quarters · filed 2025-08-14
2024-06-30$7.00K
10-Q · filed 2025-08-14
-$1.00K
10-Q · filed 2025-08-14
2024-03-31-$8.00K
10-Q · filed 2025-05-20
2023-09-30$1.00K
10-Q · filed 2024-11-14
-$1.00K
derived: sum of 2 quarters · filed 2024-11-14
-$6.00K
10-Q · filed 2024-11-14
-$26.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$2.00K
10-Q · filed 2024-08-14
-$7.00K
10-Q · filed 2024-08-14
-$27.00K
derived: sum of 3 quarters · filed 2024-08-14
-$23.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$5.00K
10-Q · filed 2024-05-15
-$25.00K
derived: sum of 2 quarters · filed 2024-05-15
-$21.00K
derived: sum of 3 quarters · filed 2024-05-15
-$22.00K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$16.00K
derived: sum of 2 quarters · filed 2024-04-01
-$17.00K
derived: sum of 3 quarters · filed 2024-04-01
$4.00K
10-K · filed 2024-04-01
2022-09-30$4.00K
10-Q · filed 2023-11-09
$3.00K
derived: sum of 2 quarters · filed 2023-11-09
$24.00K
10-Q · filed 2023-11-09
$39.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$1.00K
10-Q · filed 2023-08-07
$20.00K
10-Q · filed 2023-08-07
$35.00K
derived: sum of 3 quarters · filed 2023-08-07
$37.00K
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$21.00K
10-Q · filed 2023-05-15
$36.00K
derived: sum of 2 quarters · filed 2023-05-15
$38.00K
derived: sum of 3 quarters · filed 2023-05-15
$31.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$17.00K
derived: sum of 2 quarters · filed 2023-04-17
$10.00K
derived: sum of 3 quarters · filed 2023-04-17
$29.00K
10-K · filed 2023-04-17
2021-09-30$2.00K
10-Q · filed 2022-11-14
-$5.00K
derived: sum of 2 quarters · filed 2022-11-14
$14.00K
10-Q · filed 2022-11-14
-$33.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$7.00K
10-Q · filed 2022-08-19
$12.00K
10-Q · filed 2022-08-19
-$35.00K
derived: sum of 3 quarters · filed 2022-08-19
-$80.00K
derived: sum of 4 quarters · filed 2022-08-19
2021-03-31$19.00K
10-Q · filed 2022-05-23
-$28.00K
derived: sum of 2 quarters · filed 2022-05-23
-$73.00K
derived: sum of 3 quarters · filed 2022-05-23
-$46.00K
derived: sum of 4 quarters · filed 2022-05-23
2020-12-31-$47.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08
-$92.00K
derived: sum of 2 quarters · filed 2022-04-08
-$65.00K
derived: sum of 3 quarters · filed 2022-04-08
-$113.00K
10-K · filed 2022-04-08
2020-09-30-$45.00K
10-Q · filed 2021-11-12
-$18.00K
derived: sum of 2 quarters · filed 2021-11-12
-$66.00K
10-Q · filed 2021-11-12
2020-06-30$27.00K
10-Q · filed 2021-08-16
-$21.00K
10-Q · filed 2021-08-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36